Tiansheng Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was CNY 495.001 million compared to CNY 609.742 million a year ago. Operating loss was CNY 43.515 million compared to CNY 69.420 million a year ago. Net loss was CNY 40.479 million compared to CNY 68.491 million a year ago. Basic loss per share from continuing operations was CNY 0.1273 compared to CNY 0.2154 a year ago.